Middle East and Africa Medical Collagen Market is expected to reach US$ 26.23 million by 2028


PRESS RELEASE BY The Insight Partners 01 Sep 2021

Share this press on


The bovine segment by source is estimated to lead the market growth during the forecast period.

According to The Insight Partners market research study of “Middle East and Africa Medical Collagen Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Source, Product, Application and Country.” The Middle East and Africa medical collagen market is expected to reach US$ 26.23 million in 2028 from US$ 18.68 million in 2021; it is estimated to grow at a CAGR of 5.0% from 2021 to 2028. The report highlights trends prevailing in the Middle East and Africa medical collagen market and the factors driving market along with those that act as hindrances. 

As collagen is weakly antigenic and biodegradable, it has excellent biocompatibility. Thus, making it a primary resource in medical applications. Collagen is one of the key constituents in cosmetic formulations, as it has moisturizing, regenerating, and film-forming properties. Moreover, collagen fillers are widely used in aesthetic medicines. The subcutaneous injection of soluble collagen enhances the quality and density of the skin, thereby repairing dermatological defects. Collagen-based biomaterials have a wide range of applications in vivo and in vitro. Collagen has been widely used to develop synthetic bone graft substitutes for spine, extremities, and dental requirements. Furthermore, collagen scaffolds are developed to mimic and regenerate native tissues and are being rapidly adopted for cartilage repair. Collagen is naturally involved in the wound-healing process, and the use of collagen-based wound dressing offers several advantages for acute and chronic wound closure. Additionally, collagen dressings can control the moisture of the wound either by absorbing or providing moisture. Thus, collagen is widely used in dressings, particles, and flowable scaffolds to treat acute and chronic wounds. This wide range of applications of collagen in the medical industry is driving the growth of the market. Various players operating in the medical collagen market are developing and launching new products to expand their geographic reach and capacity to cater to a large customer base. Thus, constant advancements in products and approvals from regulatory bodies are factors further driving the growth of the medical collagen market.

Middle East has been witnessing a growing number of COVID-19 cases since its outbreak. The lockdown imposed in the wake of COVID-19 pandemic has affected the supply chain and production of various companies in the Middle East and Africa. As per the pharmacists in Riyadh, there is increased demand for nutritional supplements in Saudi Arabia since the outbreak of COVID-19. The Health Ministry of Middle East is coordinating with pharmacies to limit the quantity of nutritional supplements per customer to prevent the shortage of such items. This is likely to affect the growth of the Middle East and Africa medical collagen market.

The Middle East and Africa medical collagen market, by source, is segmented into bovine, porcine, and others. The Middle East and Africa medical collagen market, by product, is segmented into gelatine, hydrolysed collagen, native collagen, and others. Based on application, the Middle East and Africa medical collagen market has been segmented into haemostats, vascular grafts, tissue scaffolds, cartilage repair, wound care, bone grafts, diagnostics, and other. Geographically, the Middle East and Africa medical collagen market can be sub-segmented into UAE, Saudi Arabia, South Africa and Rest of Middle East and Africa.

ENCOLL Corp, GELITA AG, Collagen Matrix, Inc., Integra Life Sciences Corporation and Croda International plc are among the leading companies operating in the Middle East and Africa medical collagen market.

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com 

Download Free PDF Brochure